 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Modified Exactive MS Could Enable Thermo Fisher's Entry into Biotherapeutics Characterization Space
October 19, 2012
Modified Exactive MS Could Enable Thermo Fisher's Entry into Biotherapeutics Characterization Space
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Mass Spec Informatics and Applications Take Center Stage at ASMS 2012
May 25, 2012 / ProteoMonitor - New Products: ASMS 2012 Focus
May 25, 2012 / ProteoMonitor - ABRF Protein PTM Studies Show Field's Progress and Room for Improvement
March 23, 2012 / ProteoMonitor - Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor - Top-Down Proteomics Inching Its Way Toward the Mainstream
April 8, 2011 / ProteoMonitor